FDA Approved: ULTANE — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ULTANE (sevoflurane) submitted by AbbVie.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia

Drugs mentioned

• ULTANE (Sevoflurane)

Snippet

SUPPL AP for ULTANE (SEVOFLURANE)